Breaking News on Global Pharmaceutical Technology & Manufacturing

Make a comment > Terms and Conditions

  1. When posting or reading you agree:
    1. To accept full responsibility for the views you contribute.
    2. To use this function only for lawful purposes.
    3. Not to post defamatory, abusive, offensive, racist, sexist, threatening, vulgar, obscene, hateful or otherwise inappropriate comments, or to post comments which will constitute a criminal offence or give rise to civil liability.
    4. Not to post or make available any material which is protected by copyright, trade mark or other proprietary right without the express permission of the owner of the copyright, trade mark or any other proprietary right.
    5. Not to post any content that is advertising related.
    6. To evaluate for yourself the accuracy of any opinion, advice or other content.
    7. To supply your name and e mail address.
  2. Complaints
    1. You wish to complain about any content please use the "Report Abuse" feature and include details of your complaint, what action you would like us to take and how we can contact you.
  3. Monitoring
    1. Contributions to Make A Comment will be moderated before being published. If our attention is drawn to allegedly inappropriate content we reserve the right remove the material or the comment.
    2. Comments displaying advertising material will not be published.
    3. We reserve the right not to publish comments. Correspondence with contributors over comments which have been declined for publication will not be entertained.
  4. General
    1. We reserve the right to reveal your identity and contact details to third parties if we believe that you may have breached any of our terms and conditions.
    2. By posting material on Make a Comment, you grant all other users the right to obtain access to this material.
    3. You acknowledge that the author of each contribution is responsible for his or her comments.
    4. We are not responsible for the accuracy, veracity or reliability of any opinion, advice or statement made on Make A Comment unless it is edited by us. If un-modified by us, contributions shall not be considered to be reviewed, edited or approved by William Reed Business Media.
    5. Readers are asked to keep their comments concise and relevant to the topic in question.

Spotlight

Confusion Abounds in Elemental Impurities Testing for Pharma, Excipients
Dispatches from Excipient Fest in Baltimore - UPDATE

Confusion Abounds in Elemental Impurities Testing for Pharma, Excipients

As the USP, ICH and US FDA all aim to tackle elemental impurities testing for pharmaceuticals and...

China Looks to Tighten Excipient Regulations with Limited Resources
Dispatches from Excipient Fest in Baltimore

China Looks to Tighten Excipient Regulations with Limited Resources

China’s implementation of GMPs for excipient manufacturers, as well as a developing US FDA-style DMF system, have...

Injex Gets China Approval; Glide to Make Solid-Dose Anthrax for Pfenex

Injex Gets China Approval; Glide to Make Solid-Dose Anthrax for Pfenex

Injex says it is looking for partners to prefill its device and Glide will develop Pfenex’s anthrax...

GMP Plants and BioPharma Clusters Drive Russia's Pharma 2020

GMP Plants and BioPharma Clusters Drive Russia's Pharma 2020

International GMP standard facilities and six biopharma centres will lead Russia’s initiative in implementing its Pharma 2020...